Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies
- PMID: 15831843
- DOI: 10.1152/physiolgenomics.00259.2004
Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies
Abstract
Our understanding of the cardiovascular system has evolved through the years by extensive studies emphasizing the identification of the molecular and physiological mechanisms involved in its normal function and disease pathogenesis. Major discoveries have been made along the way. However, the majority of this work has focused on specific genes or pathways rather than integrative approaches. In cardiomyopathies alone, over 30 different loci have shown mutations with varying inheritance patterns, yet mostly coding for structural proteins. The emergence of microarrays in the early 1990s paved the way to a new era of cardiovascular research. Microarrays dramatically accelerated the rhythm of discoveries by giving us the ability to simultaneously study thousands of genes in a single experiment. In the field of cardiovascular research, microarrays are having a significant contribution, with the majority of work focusing on end-stage cardiomyopathies that lead to heart failure. Novel molecular mechanisms have been identified, known pathways are seen under new light, disease subgroups begin to emerge, and the effects of various drugs are molecularly dissected. This cross-study data comparison concludes that consistent energy metabolism gene expression changes occur across dilated, hypertrophic, and ischemic cardiomyopathies, while Ca2+ homeostasis changes are prominent in the first two cardiomyopathies, and structural gene expression changes accompany mostly the dilated form. Gene expression changes are further correlated to disease genetics. The future of microarrays in the cardiomyopathy field is discussed with an emphasis on optimum experimental design and on applications in diagnosis, prognosis, and drug discovery.
Similar articles
-
[Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy].Lakartidningen. 2005 Mar 14-20;102(11):845-7, 850-3. Lakartidningen. 2005. PMID: 15835520 Review. Swedish.
-
Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.J Mol Cell Cardiol. 2010 May;48(5):899-909. doi: 10.1016/j.yjmcc.2010.03.005. Epub 2010 Mar 16. J Mol Cell Cardiol. 2010. PMID: 20298698 Review.
-
Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?J Mol Cell Cardiol. 2010 May;48(5):882-92. doi: 10.1016/j.yjmcc.2009.10.031. Epub 2009 Nov 12. J Mol Cell Cardiol. 2010. PMID: 19914256 Review.
-
Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.Cardiovasc Res. 2021 Feb 22;117(3):694-711. doi: 10.1093/cvr/cvaa125. Cardiovasc Res. 2021. PMID: 32365198 Free PMC article. Review.
-
The genetic basis for cardiac remodeling.Annu Rev Genomics Hum Genet. 2005;6:185-216. doi: 10.1146/annurev.genom.6.080604.162132. Annu Rev Genomics Hum Genet. 2005. PMID: 16124859 Review.
Cited by
-
A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in mice.J Biol Chem. 2007 Jul 6;282(27):19556-64. doi: 10.1074/jbc.M700986200. Epub 2007 Apr 24. J Biol Chem. 2007. PMID: 17456467 Free PMC article.
-
Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart.Neuromuscul Disord. 2008 May;18(5):371-81. doi: 10.1016/j.nmd.2008.03.008. Epub 2008 Apr 25. Neuromuscul Disord. 2008. PMID: 18440230 Free PMC article.
-
Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets.J Mol Med (Berl). 2007 Mar;85(3):257-71. doi: 10.1007/s00109-006-0122-9. Epub 2006 Nov 15. J Mol Med (Berl). 2007. PMID: 17106732 Free PMC article.
-
Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure.Circ Cardiovasc Genet. 2011 Oct;4(5):475-83. doi: 10.1161/CIRCGENETICS.110.957571. Epub 2011 Aug 9. Circ Cardiovasc Genet. 2011. PMID: 21828333 Free PMC article.
-
MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.Cell Mol Life Sci. 2014 Apr;71(8):1439-52. doi: 10.1007/s00018-013-1504-0. Epub 2013 Nov 12. Cell Mol Life Sci. 2014. PMID: 24218009 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous